A Phase I study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study).
暂无分享，去创建一个
M. D. Den Boer | V. V. D. van der Velden | C. Zwaan | F. Locatelli | I. Øra | C. Rossig | B. Bielorai | I. van der Sluis | L. Sramkova | Christiane Chen-Santel | K. Nysom | B. Brethon | E. Brivio | C. Díaz-de-Heredia | Ying Chen | L. Vinti | M. López-Yurda | A. Malone | A. C. Ammerlaan | B. Sleight | A. Thano | M. Lopez-Yurda | M. D. den Boer